ACHUTTI DUSO, BRUNO
ACHUTTI DUSO, BRUNO
Dipartimento di Oncologia ed Emato-Oncologia
Caloric restriction leads to druggable LSD1-dependent cancer stem cells expansion
2024 R. Pallavi, E. Gatti, T. Durfort, M. Stendardo, R. Ravasio, T. Leonardi, P. Falvo, B.A. Duso, S. Punzi, A. Xieraili, A. Polazzi, D. Verrelli, D. Trastulli, S. Ronzoni, S. Frascolla, G. Perticari, M. Elgendy, M. Varasi, E. Colombo, M. Giorgio, L. Lanfrancone, S. Minucci, L. Mazzarella, P.G. Pelicci
NF1 AS A REGULATOR OF CYTOSKELETON DYNAMICS AND BIOMARKER FOR DECISION-MAKING IN HER2-POSITIVE BREAST CANCER
2023 B. ACHUTTI DUSO
Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life
2019 S. Morganti, P. Tarantino, E. Ferraro, P. D'Amico, G. Viale, D. Trapani, B.A. Duso, G. Curigliano
Homologous recombination deficiency in triple negative breast cancer
2019 C. Belli, B. Achutti Duso, E. Ferraro, G. Curigliano
Liver toxicity in the era of immune checkpoint inhibitors: A practical approach
2018 C. Belli, M. Zuin, L. Mazzarella, D. Trapani, P. D'Amico, E. Guerini-Rocco, B. Achutti Duso, G. Curigliano
Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer
2018 B. Duso, D. Trapani, G. Viale, C. Criscitiello, P. D'Amico, C. Belli, L. Mazzarella, M. Locatelli, I. Minchella, G. Curigliano
Targeting the microenvironment in solid tumors
2018 C. Belli, D. Trapani, G. Viale, P. D'Amico, B. Achutti Duso, P. Della Vigna, F. Orsi, G. Curigliano